Upload
bret-sermons
View
218
Download
4
Tags:
Embed Size (px)
Citation preview
10 year follow-up of central pulse pressure components and effect of nitrovasodilating therapy in
women
Marina Cecelja,
Jiang B, K McNeill, Spector T, Chowienczyk P.
Department of Clinical Pharmacology
St Thomas’ Hospital
King’s College LondonDepartment of Twin Research & Genetic Epidemiology
pPPcPP
DBP
pSBP
cSBP
Aortic PressurePeripheral Pressure
Pulse pressure
CAFE study
The CAFÉ Investigators. Differential impact of blood-lowering drugs on central aortic pressure and clinical outcomes: Principle Results of the Conduit Artery Function Evaluation (CAFÉ) Study.Circulation 2006; 113: 1213-1225
Amlodipine +perindopril
Atenolol + bendroflumethiazide
CentralSBP
BrachialSBP
P1 and AP differentially associated with aortic stiffness
Arterial dimensionsAugmentation
(AP)
Forward Pressure Wave P1: Aortic Stiffness
(↓ distension)
Cecelja et al. J Am Coll Cardiol. 2009; 18: 54: 695-703.
Inflection
Point(P1)
Aims
10-year prospective follow-up 10-year prospective follow-up
Examine the contribution of P1 and AP to age related Examine the contribution of P1 and AP to age related increase in cPP increase in cPP
Degree to which age-related increase can be reversed Degree to which age-related increase can be reversed by pharmacological vasodilation (Glyceryl Trinitrate)by pharmacological vasodilation (Glyceryl Trinitrate)
Pulse Pressure
Augmentation (AP)
Forward Pressure Wave (P1)
411 Female TwinsTWINS UK RegistryTWINS UK Registry
Department of Twin Research & Genetic Epidemiology
Visit 1 (1996 – 2001)
Visit 2 (2006 – 2010)
n = 411
Central BP Central BPCarotid BP
Arterial stiffnessArterial diameter
Visit 2
Central BP
Arterial stiffnessArterial diameter
n = 40
400 μg GTN
Aortic Pressure Waveforms:Baseline and Follow-up
Applanation tonometryApplanation tonometry High fidelity pressure transducer (Millar High fidelity pressure transducer (Millar
Instruments, Texas)Instruments, Texas) SphygmoCor System SphygmoCor System Calibrated to brachial BPCalibrated to brachial BP
Carotid pressure waveforms
• Quality control – variation in recorded waveform• n = 477
• Inconclusive - excluded
d
t1
t2
Pulse wave velocity (PWV)
Femoral
Carotid
PWV = distance transit time
SphygmoCor
Ultrasonography Arterial dimensionsArterial dimensions
Abdominal aortic
diameter
Femoral artery
diameter
Arterial diameter change expressed as a ratio: femoral/abdominal diameter
•Carotid and brachial diameters
Visit 1(n = 411)
Visit 2(n = 411)
P
Age (years) 47.6 ± 9.4 58.2 ± 9.0 < 0.0001Height (cm) 161.8 ± 6.0 161.4 ± 6.0 < 0.0001Weight (kg) 66.0 ± 11.5 69.8 ± 12.5 < 0.0001HR (bpm) 72.6 ± 11.1 63.6 ± 9.5 < 0.0001Peripheral SBP (mm Hg) 118.9 ± 15.8 125.0 ± 15.9 < 0.0001
Peripheral DBP (mm Hg) 76.1 ± 11.1 73.0 ± 8.3 < 0.0001MAP (mm Hg) 92.4 ± 13.1 92.3 ± 10.6 NS
Central SBP(mm Hg) 110.3 ± 16.0 117.1 ± 15.7 < 0.0001
Central DBP (mm Hg) 77.4 ± 11.3 73.9 ± 8.3 < 0.0001Total cholesterol (mmol/L) 5.5 ± 1.1 5.6 ± 1.0 < 0.05HDL (mmol/L) 1.5 ± 0.4 1.8 ± 0.5 < 0.0001Glucose (mmol/L) 4.6 (4.27 - 4.97) 5 (4.7 - 5.3) < 0.0001
TG (mmol/L) 1.0 (0.75 - 1.37) 0.98 (0.72 - 1.31) NS
Subject characteristics
∆ P
ress
ure
(mm
Hg) P<0.0001
P = NS
Greater increase in cPP compared to pPPin younger subjects
<50 years at baseline
≥50 years at baseline
AP contributed more than P1 to age-related increase in cPP
≥50 years at baseline
<50 years at baseline
Carotid pressure waveform: P1 and AP
Variable beta R2 P
Carotid P1Age 0.15 0.01 <0.0001MAP 0.46 0.36 <0.0001HR -0.17 0.03 <0.0001
PWV 0.29 0.07 <0.0001
Carotid APAge 0.33 0.09 <0.0001MAP 0.6 0.32 <0.0001HR -0.45 0.18 <0.0001TG 0.07 0.01 <0.05Abd Diameter -0.16 0.12 <0.0001Fem/Abd diameter -0.22 0.18 <0.0001
Multivariate regression analysis
Glyceryl Trinitrate (400 μg)Diameter Change
All P<0.0001
% D
iam
eter
Cha
nge
Glyceryl Trinitrate: P1 and AugP
∆ 9.3 mm Hg ≈ 10 years ageing
Glyceryl trinitrate: PWV and heart rate
PW
V (
m/s
ec)
NS
Errors bars = 1 SD
P<0.05
Heart
Rate
(b
pm
)
Conclusion
Augmentation pressure is an important determinant of the progression in central pulse pressure
AugP is not associated with PWV but is associated with attenuation of arterial diameter
AugP can be effectively reduced by vasodilation, independently of an effect on PWV
Discussion
Our findings challenge the conventional view that cPP is influenced predominantly by irreversible stiffening of the proximal aorta.
Suggest that drugs that dilate muscular arteries may be effective in reducing age-related widening in cPP.
Acknowledgements
British Heart Foundation British Research Council Twins UK
Department of Twin Research & Genetic Epidemiology
Age –related change in P1 and AP
AIx = AP/AP+P1
P1 and AP differentially associated with aortic stiffness
Arterial dimensionsAugmentation
(AP):
Forward Pressure Wave P1: Aortic Stiffness
(↓ distension)
Cecelja et al. J Am Coll Cardiol. 2009; 18: 54: 695-703.
Augmentation Index (AIx) = AP/cPP * 100
Inflection
Point(P1)
P1 and AP differentially associate with age?
McEniery, et al. J Am Coll Cardiol 2005;46:1753-1760
Augmentation Pressure
Augmentation Index
AP/AP+P1
Measurement of ascending aortic (top) and brachial (bottom) pressure waves at diagnostic cardiac catheterization in an older patient, by Millar micromanometer before (control) and
after administration of 0.3 mg nitroglycerin (GTN) sublingually.
O'Rourke M F , Seward J B Mayo Clin Proc. 2006;81:1057-1068
© 2006 Mayo Foundation for Medical Education and Research
Copyright ©1996 American Heart Association
Chen, C.-H. et al. Hypertension 1996;27:168-175
Tracings from all four group B patients illustrate simultaneously recorded invasively (micromanometer) and noninvasively (tonometer) obtained
carotid artery waveforms as well as the invasive (AIm) and noninvasive (AIt) augmentation indexes (expressed as percent)
Tracings from all four group B patients illustrate simultaneously recorded invasively (micromanometer) and noninvasively (tonometer) obtained
carotid artery waveforms as well as the invasive (AIm) and noninvasive (AIt) augmentation indexes (expressed as percent)
Carotid pressure waveform: P1 and AP